Silo Pharma, Inc. quarterly report, Q2 FY2017

Business Context and Reporting Period

This summary covers the Form 10-Q filed by Point Capital, Inc. (not Silo Pharma, Inc., as indicated in the metadata) for the quarterly period ended June 30, 2017. Point Capital is a closed-end, non-diversified Business Development Company (BDC) regulated under the Investment Company Act of 1940. The company invests in the common stock, preferred stock, warrants, and convertible notes of small and mid-cap companies. As of the reporting date, the company held 16 portfolio companies, all classified as non-controlled and non-affiliated.

Key Financial Metrics

Metric Six Months Ended June 30, 2017 Six Months Ended June 30, 2016
Total Assets $1,935,898 $1,299,604
Net Assets $1,515,301 $846,506
Net Asset Value (NAV) per Share $0.03 $0.02
Investment Income $13,974 $29,533
Total Operating Expenses $223,374 $274,521
Net Investment Loss $(209,400) $(244,988)
Net Realized Gain (Loss) $1,034 $23,269
Net Unrealized Gain (Loss) $877,161 $(316,746)
Net Increase in Net Assets from Operations $668,795 $(538,465)
Cash and Cash Equivalents $365,960 $426,711
Redeemable Preferred Stock $400,000 $400,000

Material Changes vs. Prior Period

  • Portfolio Valuation Surge: The fair value of investments increased from $634,873 at year-end 2016 to $1,504,654 at June 30, 2017. This was driven primarily by an unrealized gain of approximately $949,000 on the investment in IPSIDY INC. (formerly ID Global Solutions Corp.), following the conversion of debt and accrued interest into common stock in January 2017.
  • Concentration Risk: As of June 30, 2017, the IPSIDY INC. investment accounted for approximately 54% of total assets (74.24% of the portfolio), causing the company to fail the diversification test required for Regulated Investment Company (RIC) status.
  • Operating Expenses: Total operating expenses decreased by approximately 18.6% compared to the prior six-month period, largely due to a significant reduction in professional fees (legal and accounting). However, compensation expense increased by 56.5% due to payments to the CEO.
  • Liquidity: Cash and cash equivalents decreased by $213,249 during the period, primarily used to fund operating expenses.

Outlook, Risks, and Management Commentary

  • RIC Status and Excise Tax Risk: The company failed the RIC diversification test in Q1 2017. To maintain RIC status and avoid corporate-level taxation, the company must dispose of the asset causing the failure (IPSIDY INC.) within six months of the quarter-end. Failure to do so may result in a $50,000 excise tax or loss of RIC status.
  • BDC Status Withdrawal: The Board approved a proposal to withdraw the company's election to be regulated as a BDC under the 1940 Act to pursue increased investment opportunities and flexible financing. This action is contingent on identifying suitable business opportunities.
  • Internal Control Weaknesses: Management concluded that disclosure controls and procedures were ineffective as of June 30, 2017. Material weaknesses include a lack of segregation of duties, lack of Investment Act experienced staff, and lack of control over the valuation of certain investments.
  • Liquidity Outlook: Management believes existing cash and liquid investments are sufficient to meet working capital requirements for at least 12 months. However, the company has no agreements to raise capital and may need to reduce investment activities if additional funding is not secured.
  • Portfolio Specifics: Several portfolio holdings were valued at zero, including Arista Power, Inc. and MultiMedia Platforms, Inc. (which filed for Chapter 11 bankruptcy).

Investor Verification Checklist

  • RIC Compliance: Verify if the company has divested the IPSIDY INC. position to cure the diversification failure and avoid excise taxes or corporate taxation.
  • Valuation Methodology: Scrutinize the fair value determination of the IPSIDY INC. investment, which represents the majority of the portfolio's value and was valued using unobservable inputs (Level 3).
  • Internal Controls: Assess the remediation plan for the identified material weaknesses in internal controls over financial reporting.
  • BDC Withdrawal Status: Confirm whether the company has filed Form N-54C to withdraw its BDC status and the implications for future investment strategy.
  • Liquidity Runway: Monitor cash burn rates and the company's ability to fund operations without raising additional capital, given the lack of committed funding sources.